Found 38 matching trials
TACE vs TACE+SBRT for Unresectable Hepatocellular Cancer PHASE2 Vast majority of patients with hepatocellular carcinoma (HCC) present with ...
Show More Location
Advanced Centre for Treatment, Research and Education in Cancer, Tata Memorial Centre
Learn More & Join Trial
Sorafenib With TACE to Treat Hepatocellular Carcinoma PHASE1 The purpose of this study is to determine the feasibility to combine sorafe...
Show More Learn More & Join Trial
Randomized Phase II Trial of Chemoembolization and Sorafenib PHASE2 The study will be a single-center, randomized Phase II study of conventiona...
Show More Location
Smilow Cancer Center
Learn More & Join Trial
Transcatheter Arterial Chemoembolization Therapy In Combination With Sorafenib PHASE2 The purpose of this study is to evaluate the safety and efficacy of the com...
Show More Location
Kinki University Hospital
Learn More & Join Trial
Toripalimab Plus Sorafenib in Patients With Advanced-Stage Hepatocellular Carcinoma PHASE1 Toripalimab is a programmed cell death protein 1 antibody.This is an open-l...
Show More Location
Zhongshan Hospital
Learn More & Join Trial
Combination of Transcatheter Arterial Chemoembolization (TACE) and Sorafenib for Patients With Unresectable Hepatocellular Carcinoma (HCC) PHASE2 Most HCC patients are diagnosed at advanced stages in Korea, transcatheter ...
Show More Location
National Cancer Center
Learn More & Join Trial
TACE Combined With Sorafenib and Tislelizumab for Advanced HCC PHASE2 This study will evaluate the efficacy and safety of transcatheter arterial ...
Show More Location
The 2nd Affiliated Hospital of Guangzhou Medical University
Learn More & Join Trial
Evaluation Effectiveness and Safety of (cTACE or DEB-TACE + FOLFOX Regimen HAIC) Combined With Camrelizumab and Apatinib Mesylas in the Treatment of Advanced Hepatocellular Carcinoma PHASE2 This study used (cTACE or DEB-TACE + FOLFOX scheme HAIC) combined with PD-1...
Show More Location
Multiple Locations
Learn More & Join Trial
Effectiveness and Safety Study of TACE Plus Oral Sorafenib for Unresectable HCC PHASE2 The purpose of this study is to determine if TACE plus Sorafenib will impro...
Show More Location
University of Pittsburgh Cancer Institute
Learn More & Join Trial
Sorafenib Chemoembolization Evaluation Controlled Trial PHASE3 This prospective, multicenter, randomized, controlled study aims to evaluat...
Show More Location
Xijing Hospital of Digestive Disease
Learn More & Join Trial